Skip to main content

Pfizer Constructs New Jersey Facilities

Published 1/25/2006

Pfizer is planning a three-phase expansion of its New Jersey operations. Phase one is comprised of construction of a $218.5-million, 250,000-sf research and development building in Morris Plains. Phase two is construction of a 450,000-sf to 500,000-sf office facility, also in Morris Plains. Phase three consists of construction of a 160,000-sf research and development addition, including renovation of adjacent space for manufacturing support in Parsippany.